Juan D. Garisto, MD | Authors

Po Box 58488

Articles

Active Surveillance for Prostate Cancer: How to Do It Right

May 16, 2017

In this review of active surveillance for favorable-risk prostate cancer, we will discuss the rationality of this approach, the biological evidence for employing active surveillance in Gleason pattern 3 and 4 prostate cancer, patient selection for active surveillance, clinical trial data on active surveillance, and the role of prostate cancer biomarkers and imaging studies for clinical decision making in patients with low-risk disease.